Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – For patients with high platelet reactivity after percutaneous coronary intervention, treatment with a high-dose clopidogrel regimen does not improve outcomes compared with standard…
NEW YORK (Reuters Health) – Premature babies who received a packed red blood cell (PRBC) transfusion were more than twice as likely to develop necrotizing entercolitis (NEC) as…
NEW YORK (Reuters Health) – Current evidence is still inconclusive as to whether patients with chronic kidney disease (CKD) may benefit from aggressive blood pressure control, according to…
NEW YORK (Reuters Health) – Measurements of intraocular pressure (IOP) may depend on which eye is measured first, according to a new study published in the Archives of…
NEW YORK (Reuters Health) – For reducing pain from venipuncture in newborn infants, oral sucrose is more effective than topical liposomal lidocaine, according to the results of a…
NEW YORK (Reuters Health) – A single dose of zoledronate prevents bone loss associated with glucocorticoid therapy given for acute exacerbation of Crohn’s disease, a German team reports…
NEW YORK (Reuters Health) – An updated review of medications available for treating type 2 diabetes concludes that metformin continues to have the best benefit-to-harm profile, according to…
Vincent A. DeLeo, MD, Chairman, Department of Dermatology, St Luke’s – Roosevelt Hospital, New York, discusses sunscreens and FDA testing and labeling for photoprotection. The sunburn protection factor,…
Nanette B. Silverberg, MD, director of Pediatric and Adolescent Dermatology St. Luke’s – Roosevelt Hospital Center, New York, discusses melanoma and its increasing incidence. This has occurred in…
NEW YORK (Reuters Health) – The incidence of esophageal adenocarcinoma in patients with nondysplastic Barrett’s esophagus is lower than previously reported, so less rigorous surveillance may be possible,…
